Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
Anna Bujak, Patrycja Nejman-Gryz, Pawel Gunerka, Monika Lamparska-Przybysz, Maciej Wieczorek, Ryszarda Chazan, Aleksandra Stanczak
European Respiratory Journal 2014 44: 3413; DOI:
Anna Bujak
1Innovative Drugs R&D Department, Celon Pharma Inc., Kielpin/Lomianki, Poland
2Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland
Patrycja Nejman-Gryz
3Deptartment of Internal Diseases, Pneumology and Allergology, Medical University of Warsaw, Warsaw, Poland
Pawel Gunerka
1Innovative Drugs R&D Department, Celon Pharma Inc., Kielpin/Lomianki, Poland
4Department of Medical Biotechnology, Medical University of Lodz, Lodz, Poland
Monika Lamparska-Przybysz
1Innovative Drugs R&D Department, Celon Pharma Inc., Kielpin/Lomianki, Poland
Maciej Wieczorek
1Innovative Drugs R&D Department, Celon Pharma Inc., Kielpin/Lomianki, Poland
Ryszarda Chazan
3Deptartment of Internal Diseases, Pneumology and Allergology, Medical University of Warsaw, Warsaw, Poland
Aleksandra Stanczak
1Innovative Drugs R&D Department, Celon Pharma Inc., Kielpin/Lomianki, Poland
Vol 44 Issue Suppl 58
Table of Contents
Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma
Anna Bujak, Patrycja Nejman-Gryz, Pawel Gunerka, Monika Lamparska-Przybysz, Maciej Wieczorek, Ryszarda Chazan, Aleksandra Stanczak
European Respiratory Journal Sep 2014, 44 (Suppl 58) 3413;